Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Peritoneal Neoplasms 1

Interventions

Paclitaxel 9Carboplatin 6Cisplatin 5Hyperthermic Intraperitoneal Chemotherapy 4Oxaliplatin 3Fluorouracil 3Cytoreduction Surgical Procedures 3Bevacizumab 3nintedanib 2Mitomycin 2Leucovorin 2Laparoscopy 2Gemcitabine 2Folfox protocol 2Docetaxel 2vandetanib 1talimogene laherparepvec 1strattice 1sodium thiosulfate 1poly(I).poly(c12,U) 1pembrolizumab 1olaparib 1nilotinib 1liposomal doxorubicin 1lentiviral minigene vaccine of COVID-19 coronavirus 1farletuzumab 1enzastaurin 1catumaxomab 1birinapant 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Peritoneal Neoplasms × Acids × Clear all
NCT02151448 2020-07-20

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

University of Pittsburgh

Phase 1/2 Completed
64 enrolled 18 charts
Gynecologic

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡